← Browse by Condition

Medical Condition

inflammation

Total Trials

22

Recruiting Now

22

Trial Phases

Phase 2, Phase 1, Phase 4

ClinicalMetric tracks all active clinical trials for inflammation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — inflammation Clinical Trials

How many clinical trials are currently recruiting for inflammation?

ClinicalMetric currently tracks 22 actively recruiting clinical trials for inflammation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 22. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for inflammation?

inflammation research spans Phase 1 (1 trial), Phase 2 (4 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a inflammation clinical trial?

Eligibility criteria for inflammation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

1

Phase 2

4

Phase 4

1

Top Sponsors

Universidade Federal Fluminense 2 trials

Peking Union Medical College Hospital 1 trial

University of Catanzaro 1 trial

University of California, Davis 1 trial

Vrinnevi Hospital 1 trial

Recruiting Clinical Trials

Disease Characteristics of IR-CAD: a Case-control Study

Peking Union Medical College H...

Diamagnetic Therapy in Pain and Inflammation

University of Catanzaro

Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc

University of California, Davi...

Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation

Vrinnevi Hospital

NCT06136546 Phase 2

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Massachusetts General Hospital

NCT05969275 Phase 2

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

Ottawa Hospital Research Insti...

NCT07579182 Phase 1

Hormones, Outcomes, and Pain Pathways in Exercise Study

University of Houston

EFFECTS OF PROPOLIS AND ROYAL JELLY SUPPLEMENTATION ON INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION

Universidade Federal Fluminens...

NCT06420752 Phase 2

Passive Stretching in Peripheral Arterial Disease Patients

University of Wisconsin, La Cr...

NCT03889743 Phase 4

Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing

Finland, Norway, Swe...

St. Olavs Hospital

Lymphedema, Low-grade Inflammation and the Vasculature in Turner Syndrome

University of Aarhus

Validation and Simplification of the Retinol Isotope Dilution Technique in Burkinabe Schoolchildren

Institut de Recherche en Scien...

Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.

University of Texas at Austin

Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function

Oregon Health and Science Univ...

Impact of Vascular Calcification and CASR Expression by Monocytes in Septic Shock

Centre Hospitalier Universitai...

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial

King's College London

Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia

University of Bologna

DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes

Hubei Cancer Hospital

Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia

Universidade Federal Fluminens...

Efficacy of SGLT2 Inhibitors in Adults With Sepsis

Hospital Authority, Hong Kong

CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

Rigshospitalet, Denmark

NCT06130059 Phase 2

Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

University of Texas Southweste...

Related Conditions

septic shock (2) sepsis (2) cardiovascular diseases (2) coronary artery disease (1) coronary artery stenosis (1) coronary artery restenosis (1) coronary artery disease progression (1) inflammatory disease (1) inflammation vascular (1) pain (1) zinc deficiency (1) metabolic diseases (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology